agilon health(US:AGL) Prnewswireยท2025-09-13 01:37Core Viewpoint - Kahn Swick & Foti, LLC is investigating agilon health, inc. following a significant reduction in its 2023 profit forecasts and subsequent legal actions against the company and its executives for failing to disclose material information [1][2]. Group 1: Company Financials - Agilon health, inc. has lowered its 2023 Medical Margin expectation to a range of $340 million to $360 million, which is approximately $110 million below previous guidance due to $90 million in higher-than-expected medical costs [1]. - The company's Chief Financial Officer, Timothy Bensley, is set to retire later in the year [1]. Group 2: Legal Proceedings - A securities class action lawsuit has been filed against agilon and certain executives, alleging violations of federal securities laws by failing to disclose material information during the Class Period [2]. - The court has denied the company's motion to dismiss the case, allowing the lawsuit to proceed [2]. - KSF's investigation is focused on whether agilon's officers and/or directors breached their fiduciary duties to shareholders or violated state or federal laws [2]. Group 3: Kahn Swick & Foti, LLC Overview - Kahn Swick & Foti, LLC is recognized as one of the top boutique securities litigation law firms in the U.S., with a focus on recovering investment losses due to corporate fraud [3]. - The firm has been ranked among the top 10 nationally based on total settlement value [3]. - KSF serves a diverse clientele, including public and private institutional investors, as well as retail investors [3].